Coronary Blood Flow: Integrated Theory and Experiments

冠状动脉血流:理论与实验相结合

基本信息

  • 批准号:
    9457478
  • 负责人:
  • 金额:
    $ 65.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-10 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Blood flow and rate of oxygen consumption are closely matched in vivo under normal conditions. Coronary flow is regulated through the combined action of metabolic, adrenergic, and mechanical (myogenic and shear) mechanisms. Since vascular mechanical processes are linked to the mechanics of cardiac contraction, understanding flow regulation requires a model that accounts for mechanics from the microvessel to the whole-organ level. Accordingly, the overall objective of this grant is to develop a validated multi-scale model of coronary autoregulation that accounts for the various major determinants of coronary flow regulation. To accomplish this goal, we set the following three Specific Aims: Aim 1: To construct a multi-scale mechanistic model of coronary flow regulation integrating cell-level models of endothelial and smooth-muscle function, single-vessel mechanics of coronary resistance arteries, autonomic function, network-level myocardium- coronary vessel interaction and conducted metabolic response; Aim 2: To validate the ability of the model of Aim 1 to predict physiological dynamics observed in the awake exercising pig; and Aim 3: To use the models from Aim 1, refined by data from Aim 2 to understand the multiscale effects of stenosis on pulsatile flow in coronary arteries. We will test the hypothesis that the multiple parallel control mechanisms fail when coronary arteries become stenotic because they act out of sync and interfere. The model predictions will be compared to data from three complimentary protocols: (1) dynamic measurements of flow, pressure, and diameter in coronary arteries ranging from 50 mm to the large epicardial vessels; (2) steady-state measurements of venous (coronary sinus) pO2 versus left-ventricular oxygen consumption in different exercise states; and (3) measurement of the dynamic reactive hyperemic response flow following acute transient occlusion of the left anterior descending coronary artery. Protocols will be conducted with and without specific pharmacological interventions to inhibit receptors and channels represented in the cell-level models. The validated model will be used to investigate critical questions, including: What is the principle mechanism coupling coronary blood flow to metabolism in vivo? How is high resting oxygen extraction functionally linked to the ability of the system to effectively respond to increased demand in exercise?
描述(由申请人提供):在正常条件下,血流量和耗氧率在体内密切匹配。冠状动脉血流通过代谢、肾上腺素能和机械(肌源性和剪切)机制的联合作用来调节。由于血管机械过程与心脏收缩的力学有关,因此理解流量调节需要一个模型,该模型可以解释从微血管到整个器官水平的力学。因此,这项资助的总体目标是开发一个经验证的冠状动脉自动调节的多尺度模型,该模型解释了冠状动脉流量调节的各种主要决定因素。为了实现这一目标,我们设定了以下三个具体目标:目标1:构建冠状动脉血流调节的多尺度机制模型,该模型整合了内皮和平滑肌功能的细胞水平模型、冠状动脉阻力动脉的单血管力学、自主神经功能、网络水平心肌-冠状动脉血管相互作用和传导代谢反应;目标2:验证目标1模型预测清醒运动猪中观察到的生理动力学的能力;目标3:使用目标1的模型,通过目标2的数据进行细化,以了解狭窄对冠状动脉脉动流的多尺度影响。我们将检验这样一个假设:当冠状动脉狭窄时,多个平行控制机制失效,因为它们的行为不同步并相互干扰。模型预测将与来自三个补充协议的数据进行比较:(1)从50 mm到大心外膜血管的冠状动脉中的流量、压力和直径的动态测量;(2)静脉血管的稳态测量。不同运动状态下冠状窦pO 2与左心室耗氧量的关系;(3)左冠状动脉前降支急性短暂闭塞后动态反应性充血反应血流的测量。协议 将在有或没有特定药理学干预的情况下进行,以抑制细胞水平模型中代表的受体和通道。经验证的模型将用于研究关键问题,包括:什么是耦合冠状动脉血流代谢在体内的原则机制?高静息氧提取量与系统有效响应运动需求增加的能力在功能上有何联系?

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dynamic Regulation of the Subunit Composition of BK Channels in Smooth Muscle.
平滑肌 BK 通道亚基组成的动态调节。
  • DOI:
    10.1161/circresaha.117.311723
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    20.1
  • 作者:
    Dick,GregoryM;Tune,JohnathanD
  • 通讯作者:
    Tune,JohnathanD
Integrative model of coronary flow in anatomically based vasculature under myogenic, shear, and metabolic regulation.
在肌源性、剪切力和代谢调节下基于解剖学的脉管系统中冠状动脉血流的综合模型。
  • DOI:
    10.1085/jgp.201711795
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Namani,Ravi;Kassab,GhassanS;Lanir,Yoram
  • 通讯作者:
    Lanir,Yoram
Coronary Blood Flow Is Increased in RV Hypertrophy, but the Shape of Normalized Waves Is Preserved Throughout the Arterial Tree.
右心室肥厚时冠状动脉血流量增加,但整个动脉树保持正常波的形状
  • DOI:
    10.3389/fphys.2018.00675
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Huo Y;Kassab GS
  • 通讯作者:
    Kassab GS
Open-loop (feed-forward) and feedback control of coronary blood flow during exercise, cardiac pacing, and pressure changes.
运动、心脏起搏和压力变化期间冠状动脉血流的开环(前馈)和反馈控制。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL A BEARD其他文献

DANIEL A BEARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL A BEARD', 18)}}的其他基金

Systems and Integrative Biology Training Program
系统和综合生物学培训计划
  • 批准号:
    10714106
  • 财政年份:
    2023
  • 资助金额:
    $ 65.05万
  • 项目类别:
Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling
通过多尺度建模阐明冠状动脉血流调节机制
  • 批准号:
    10592338
  • 财政年份:
    2022
  • 资助金额:
    $ 65.05万
  • 项目类别:
Computational systems analysis of cardiac mechanical-energetic coupling in heart disease
心脏病中心脏机械-能量耦合的计算系统分析
  • 批准号:
    10094080
  • 财政年份:
    2019
  • 资助金额:
    $ 65.05万
  • 项目类别:
Computational systems analysis of cardiac mechanical-energetic coupling in heart disease
心脏病中心脏机械-能量耦合的计算系统分析
  • 批准号:
    10376181
  • 财政年份:
    2019
  • 资助金额:
    $ 65.05万
  • 项目类别:
Multi-scale systems analysis of blood pressure control and hypertension
血压控制和高血压的多尺度系统分析
  • 批准号:
    10117280
  • 财政年份:
    2018
  • 资助金额:
    $ 65.05万
  • 项目类别:
Multi-scale modeling to predict and refine genotype-to-phenotype relationships in mammals
用于预测和完善哺乳动物基因型与表型关系的多尺度建模
  • 批准号:
    9789879
  • 财政年份:
    2018
  • 资助金额:
    $ 65.05万
  • 项目类别:
Coronary Blood Flow: Integrated Theory and Experiments
冠状动脉血流:理论与实验相结合
  • 批准号:
    8803070
  • 财政年份:
    2013
  • 资助金额:
    $ 65.05万
  • 项目类别:
Coronary Blood Flow: Integrated Theory and Experiments
冠状动脉血流:理论与实验相结合
  • 批准号:
    8731967
  • 财政年份:
    2013
  • 资助金额:
    $ 65.05万
  • 项目类别:
Mechanisms of Metabolic Dysfunction in Type 2 Diabetes
2 型糖尿病代谢功能障碍的机制
  • 批准号:
    9033896
  • 财政年份:
    2012
  • 资助金额:
    $ 65.05万
  • 项目类别:
Mechanisms of Metabolic Dysfunction in Type 2 Diabetes
2 型糖尿病代谢功能障碍的机制
  • 批准号:
    8271621
  • 财政年份:
    2012
  • 资助金额:
    $ 65.05万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 65.05万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 65.05万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 65.05万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 65.05万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 65.05万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 65.05万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 65.05万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 65.05万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 65.05万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 65.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了